| June 8, 2010 |
|
| |
Protein Production Services Ltd. (PPS) is proud to announce that an important milestone towards the establishment of its FDA/EMEA compliant cGMP manufacturing plant has been reached.
|
| Read More. |
| |
| February 22, 2010 |
|
| |
| PPS is proud to announce that it was selected to participate in the EU 7th Framework Programme (FP7) for Research & Technological Development. The company will be part of a Stem Cell Consortium entitled "Cardio Repair European Multidisciplinary Initiative", which is due to start on April 1, 2010. |
| Read More. |
| |
| September 1, 2009 |
|
| |
PPS has entered into an agreement with BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, for cGMP production of BrainStorm's stem cell therapeutic product. The clinical-grade product will be used in a pre-clinical safety trial for the company’s innovative therapy for ALS.
|
| Read More. |
| |
| December 14, 2009 |
|
| |
| Protein Production Services Ltd. (PPS) announced today that the company had been awarded a second year grant from Israel's prestigious Office of the Chief Scientist (OCS) program of support for industrial R&D. The grant was designated by the OCS to partially fund the continuation of Factor VIIa process development and production program, as a part of the company's platform of "Biosimilars Plus". |
| Read More. |
| |
| March 10. 2009 |
|
| |
| Seraffix started Phase I clinical trials that will include 15 patients. A clinical batch of the protein component for the trial was prepared and released by PPS. |
| Read More. |
| |
| February 10, 2009 |
|
| |
| PPS Participated in a business delegation to Thistle Bioscience Showcase Event in Edinburgh, Scotland on February 3-6 2009. The mission was organized by the UK Trade & Investment as part of its ongoing programme of developing links between the UK and Israel in the life sciences sector. |
| Read More. |
| |
| January 19, 2009 |
|
| |
| Dr. Eli Opper, Chief Scientist of the Ministry of Industry, Trade and Labor, visited PPS and was introduced to the company's facilities and services. |
| Read More. |
| |
| December 28, 2008 |
|
| |
| Protein Production Services Ltd. (PPS) announced today that the company had been awarded a grant from Israel's prestigious Office of Chief Scientist (OCS) program of support for industrial R&D. The company will receive approximately 800,000 NIS throughout October 1, 2008 to September 30, 2009 to fund the process development and production of Factor VIIa. |
| Read More. |
| |
| July 20, 2008 |
|
| |
| GammaCan Announces Positive Testing Results in the Development of VitiGam™ for the Treatment of Melanoma. The experiments were performed using IgG batches prepared by PPS. |
| Read More. |
| |
| April 22, 2008 |
|
| |
| PhiloGene Inc. Announces Revolutionary Advances in the Treatment of Cancer and Macular Degeneration at BIO National Venture Conference 2008. The preclinical anti-cancer and ophthalmic experiments were performed using VEGFb produced by PPS. |
| Read More. |
| |
| February 8, 2008 |
|
| |
PPS and PhiloGene Announce Collaboration to Develop and Manufacture PLG101 and PLG201.
Tel Aviv, February 8, 2008. Protein Production Services Ltd. (PPS), an Israeli biopharmaceutical company whose core business is contract manufacturing, and PhiloGene Inc., a biopharmaceutical company, announced today the signing of an agreement for the development and supply of PLG101 and PLG201... |
| Read More. |
| |
| January 28, 2008 |
|
| |
| PPS has relocated! Our new site remains within the Science Park of Rehovot-Ness Ziona, and the phone number remains the same. The new address is 7 Golda Meir St, Kiryat Weizmann Science Park, Ness Ziona 74036. |
| |
| December 20, 2007 |
|
| |
| PPS was invited to participate in the Israeli Business Delegation to the Genesis VII Conference & UK Biotechnology Company Showcase that took place in London on 11-15 December 2007. The delegation was sponsored by the UK Trade & Investment Office of the British Embassy in Tel Aviv as part of the ongoing programme of developing biotechnology links between the UK and Israel. |
| Read More. |
| |
| October 18, 2007 |
|
| |
| PPSV was granted IS 500,000 by the Start-up Fund of the Ministry of National Infrastructures to carry out its project entitled "Cost Effective Enzyme-Based Degradation of Cellulosic Waste to Ethanol". The grant reflects the policy of the Ministry with regard to promotion of energy efficiency and the use of alternative and renewable energy. |
| |
| October 1, 2007 |
|
| |
PPS is announcing that Dr. Meir Fischer has joined the company as Executive VP Development. Dr. Fischer has 27 years of experience in industrial biotechnology, and for the last 8 years held a position of VP Development at Bio-Technology General, Israel. His vast expertise will be an asset for the company and its customers.
|
| |
| July 5, 2007 |
|
| |
| The bi-national R&D program of the Korea-Israel Industrial Foundation (KORIL-RDF) has approved a joint proposal of Protein Production Services (Israel) and DAMO Cosmetics (Republic of Korea) entitled "Development and commercialization of anti-aging applications based on recombinant human Growth Hormone and its stimulators from herbal extracts origin". The project was granted a total of $943,622 over 3 years, of which 50% will be paid by KORIL-RDF. |
| |
